Clinical Trials of Antidepressants : How Changing the Model Can Uncover New, More Effective Molecules (Springerbriefs in Psychology)

個数:
電子版価格
¥10,007
  • 電子版あり

Clinical Trials of Antidepressants : How Changing the Model Can Uncover New, More Effective Molecules (Springerbriefs in Psychology)

  • オンデマンド(OD/POD)版です。キャンセルは承れません。
  • ≪洋書のご注文について≫ 「海外取次在庫あり」「国内在庫僅少」および「国内仕入れ先からお取り寄せいたします」表示の商品でもクリスマス前(12/20~12/25)および年末年始までにお届けできないことがございます。あらかじめご了承ください。

  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 66 p.
  • 言語 ENG
  • 商品コード 9783319264639

Full Description

This brief guide takes current clinical trial protocols to
task and replaces them with a contemporary framework for improving
next-generation antidepressants and their underlying science. Innovative models
are based on a nuanced, neurologically-informed understanding of drug
mechanisms and the component cognitive, mood, and behavioral aspects of
depression. The book reconceptualizes not only the clinical trial process but
the clinical concept of depression itself as essential to bringing
pharmaceutical research and development up to date, boosting efficiency and
effectiveness, finding new molecules, and reducing waste. Case studies and a
review of salient depression scales illustrate the potential benefits of such
wide-scale change. 

Included in the coverage: 

Why
now the need for a new clinical trials model for antidepressants?
Aims
and basic requirements of clinical trials: conventional and
component-specific models.
Methods
for measuring the components and the profile of drug actions: the
multivantaged approach.
Achieving
the ideal clinical trial: an example of the merged componential and
established models.
Prediction
and shortening the clinical trial.
The
video clinical trial. 

Clinical Trials of
Antidepressants will interest a varied audience, including clinical
investigators, academic and pharmaceutical company scientists, clinical trial
organizations, psychiatrists, outpatient physicians, psychotherapists, clinical
psychologists, psychology graduate students, medical students, and government
agencies such as the FDA.

Contents

Introduction.- Why Now the Need for a New Clinical Trial Model for Antidepressants?.- Reconceptualizing Depression and the Componential-Specific Model of Clinical Trials.- Aims and Basic requirements of Clinical Trials: Conventional and Component-Specific Models.- Methods for Measuring the Components and Profile of Drug Actions: The Multivantaged Approach.- The Component-Specific Model Applied in a Clinical Trial: An Example.- Comparing the Component-Specific Model Directly with the Established Diagnosis-Specific Trial.- Prediction and Shortening the Clinical Trial: Further Advantages of the Component-Specific Model.- The Video Clinical Trial and the VIBES Method.- Conclusions.

最近チェックした商品